Manuscripts
Showing 1543 manuscripts.
Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials
Citation
Brooks Jackson, Kim Sannerud, Henry H. Balfour. Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials. Journal of Acquired Immune Deficiency Syndromes. 1989. 2: 394-7.Year
1989
Journal
Journal of Acquired Immune Deficiency Syndromes
Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs
Citation
Brooks Jackson, Shirley Y. Kwok, J. S. Hopsicker, Kim Sannerud, John Sninsky, J. R. Edson, Henry H. Balfour. Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. TRANSFUSION. 1989. 29: 265-7.Year
1989
Journal
TRANSFUSION
Results of the flow cytometry ACTG quality control program: analysis and findings
Citation
Helene M.A. Paxton, Pamela Gill Kidd, Alan Landay, Janis V. Giorgi, Neal Flomenberg, Edwin B. Walker, Fred T. Valentine, John L. Fahey, Rebecca S. Gelman. Results of the flow cytometry ACTG quality control program: analysis and findings. Clinical Immunology and Immunopathology (Now Clin Immunol). 1989. 52: 68-84.Year
1989
Journal
Clinical Immunology and Immunopathology (Now Clin Immunol)
Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro
Citation
Richard S. Kornbluth, Philip S. Oh, James R. Munis, Patrick H. Cleveland, Douglas D. Richman. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. Journal of Experimental Medicine. 1989. 169: 1137-51.Year
1989
Journal
Journal of Experimental Medicine
Probenecid and zidovudine metabolism
Citation
David Kornhauser, Brent Gray Petty, Craig Hendrix, Amina S. Woods, Lynda Nerhood, John G. Bartlett, Paul S. Lietman. Probenecid and zidovudine metabolism. Lancet. 1989. 2: 473-5.Year
1989
Journal
Lancet
Why high levels of virus-specific CTL persist in HIV1-infected individuals
Citation
Richard A. Koup, John L. Sullivan. Why high levels of virus-specific CTL persist in HIV1-infected individuals. Research In Immunology. 1989. 140: 92-5.Year
1989
Journal
Research In Immunology
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
Citation
Brendan Larder, G. Darby, Douglas D. Richman. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989. 243: 1731-4.Year
1989
Journal
Science
Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR
Citation
David M Markovitz, Shannon Kenney, J. Kamine, Marilyn S. Smith, Marilyn Davis, E. Huang, C. Rosen, Joseph S. Pagano. Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. Virology. 1989. 173: 750-4.Year
1989
Journal
Virology
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a phase I and II study
Citation
Thomas C. Merigan, Gail Skowron, Sam Bozzette, Douglas D. Richman, Raj B. Uttamchandani, Margaret A. Fischl, Robert T. Schooley, Martin S. Hirsch, Whaijen Soo, Carla Pettinelli, Herbert H. Schaumburg. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a phase I and II study. Annals of Internal Medicine. 1989. 110: 189-94.Year
1989
Journal
Annals of Internal Medicine
Measurement of human immunodeficiency virus load and its relation to disease progression
Citation
Lee Ratner. Measurement of human immunodeficiency virus load and its relation to disease progression. AIDS Research and Human Retroviruses. 1989. 5: 115-9.Year
1989
Journal
AIDS Research and Human Retroviruses